Manufacturing Equipment, Biologics

Demonstrating a Fully Continuous Bioprocess

May 16, 2022

Flexible and efficient methods are needed for biopharmaceutical manufacturing.

Implementing Continuous Bioprocessing: From Theory to Practice

May 16, 2022

The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.

Thermo Fisher Scientific Invests $40 Million to Expand Bioprocessing Manufacturing Site

February 17, 2022

Thermo Fisher Scientific is expanding its Millersburg, Penn., site with a $40 million investment to support increased production of single-use technology for critical vaccines and biologics.

Single-Use Systems in Downstream Processes

February 10, 2022

PharmTech interviewed Sartorius about SUS innovations and trends.

Accelerating Workforce Training on Single-Use Technologies

February 03, 2022

Training is crucial for supporting GMP operations in commercial-scale bioprocessing.

Piramal Pharma Invests Minority Stake in India-Based CDMO, Yapan Bio

January 05, 2022

With this investment into Yapan Bio, Piramal Pharma adds new technologies and capabilities in large molecules, including vaccines and gene therapies, to its global offering.

Addressing the Training Gap for Single-Use Technologies

January 03, 2022

Workforce training is crucial for biopharmaceutical manufacturing.

New Isolator for Cell and Gene Therapy Manufacturing

December 13, 2021

SKAN’s new Cellana isolator is designed for GMP manufacturing of ATMPs.

Analytics Advances for Optimizing Downstream Processes

December 03, 2021

Simple, inexpensive real-time analytics are urgently needed for high value products.

GenScript Opens New Gene Synthesis Center in New Jersey

November 04, 2021

GenScript’s new gene synthesis center in Piscataway, NJ, is highly automated to accelerate production time and increase supply chain resiliency for biopharma and synthetic biology.